Recently, the Missouri Department of Mental Health approved pharmacists to step into the role of psychiatric care provider. The decision has created a more efficient community treatment team. Since community psychiatry involves reaching out to people wherever you find them (at home, in restaurants, even under bridges) to provide care and support, it is difficult […]
Clinical pharmacist Candis Morello serves as the director of San Diego Department of Veterans Affairs (VA) Diabetes Intense Medical Management (DIMM) clinic. With her counseling, veterans with a history of type II diabetes are learning how to improve their condition.
Photo courtesy of the Drug Enforcement Administration Do you have unneeded or expired medications lingering around in your home? This Saturday, the Drug Enforcement Administration (DEA) will be hosting its National Drug Take-Back Day to collect unwanted, unneeded, or expired medications free and anonymously. We at RPh on the Go encourage you to take part […]
If there was an emergency in your local area right now, would you be ready? The Centers for Disease Control and Prevention (CDC) want you to focus on being ready for anything at anytime – and that’s what September is all about. 2014 is the 11th year for the National Preparedness Month – sponsored by […]
In June, Valeant Pharmaceuticals International Inc. announced FDA approval for their medication Jublia, or efinaconazole. The topical solution is approved for the treatment of toenail onychomycosis as a result of either Trichophyton rubrum or Trichophyton mentagrophytes.
August is National Immunization Awareness Month. It’s the perfect time to discuss immunizations with patients who come in to pick up their regular prescriptions. Many people are under the impression that vaccines are just for children, but the fact is that adults are just as susceptible to many conditions. Vaccinations are important year round, not […]
In late June, MannKind Corp. announced the FDA approved their product, an inhaled form of insulin, known as Afrezza.
In July, Bristol-Myers Squibb announced the recall of some of their 5 mg single-use Coumadin injections. Six lots are affected in the recall: 00201125, 00201126, 00201127, 00201128, 00201129, and 00201130. The voluntary nationwide recall is a result of visible particulate matter found in some unreleased samples. These lots were distributed in six-count cartons to pharmacies […]
